SG11201901834WA - Micrornas as biomarkers for endometriosis - Google Patents
Micrornas as biomarkers for endometriosisInfo
- Publication number
- SG11201901834WA SG11201901834WA SG11201901834WA SG11201901834WA SG11201901834WA SG 11201901834W A SG11201901834W A SG 11201901834WA SG 11201901834W A SG11201901834W A SG 11201901834WA SG 11201901834W A SG11201901834W A SG 11201901834WA SG 11201901834W A SG11201901834W A SG 11201901834WA
- Authority
- SG
- Singapore
- Prior art keywords
- mir
- international
- pct
- endometriosis
- english
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Pregnancy & Childbirth (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662381130P | 2016-08-30 | 2016-08-30 | |
| PCT/US2017/049284 WO2018044979A1 (fr) | 2016-08-30 | 2017-08-30 | Micro-arn servant de biomarqueurs de l'endométriose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201901834WA true SG11201901834WA (en) | 2019-03-28 |
Family
ID=61301726
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201901834WA SG11201901834WA (en) | 2016-08-30 | 2017-08-30 | Micrornas as biomarkers for endometriosis |
| SG10202102509TA SG10202102509TA (en) | 2016-08-30 | 2017-08-30 | Micrornas as biomarkers for endometriosis |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202102509TA SG10202102509TA (en) | 2016-08-30 | 2017-08-30 | Micrornas as biomarkers for endometriosis |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US10982282B2 (fr) |
| EP (1) | EP3506912B1 (fr) |
| JP (2) | JP2019528081A (fr) |
| KR (1) | KR20190057305A (fr) |
| CN (1) | CN109890394A (fr) |
| AU (1) | AU2017319325A1 (fr) |
| BR (1) | BR112019004075A2 (fr) |
| CA (1) | CA3035429A1 (fr) |
| MX (1) | MX2019002425A (fr) |
| SG (2) | SG11201901834WA (fr) |
| WO (1) | WO2018044979A1 (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015148919A2 (fr) | 2014-03-27 | 2015-10-01 | Yale University | Micro-arn circulants en tant que biomarqueurs pour l'endométriose |
| CA3035429A1 (fr) | 2016-08-30 | 2018-03-08 | Yale University | Micro-arn servant de biomarqueurs de l'endometriose |
| EP3676395A4 (fr) * | 2017-08-30 | 2021-09-01 | Dot Laboratories, Inc. | Méthodes et compositions de détection et de traitement de l'endométriose |
| EP3820483A4 (fr) * | 2018-07-13 | 2023-03-01 | Yale University | Compositions et méthodes de traitement de l'endométriose |
| KR102089559B1 (ko) * | 2018-08-31 | 2020-03-16 | 차의과학대학교 산학협력단 | 난소의 fsh에 대한 반응성의 진단 또는 예측용 바이오마커 및 이의 용도 |
| US11315660B2 (en) | 2018-10-31 | 2022-04-26 | Dot Laboratories, Inc. | Method of detecting and treating endometriosis in a female subject |
| WO2020092672A2 (fr) * | 2018-10-31 | 2020-05-07 | Yale University | Algorithme quantitatif pour endométriose |
| WO2020146544A1 (fr) * | 2019-01-09 | 2020-07-16 | Research Institute At Nationwide Children's Hospital | Nouveau procédé de surveillance de l'endométriose et de troubles associés |
| JPWO2020179895A1 (fr) | 2019-03-07 | 2020-09-10 | ||
| ES2787725A1 (es) * | 2019-04-15 | 2020-10-16 | Univ Granada | Metodo de obtencion de datos utiles para diagnosticar telangiectasia hemorragica hereditaria |
| CN110144394A (zh) * | 2019-04-18 | 2019-08-20 | 辽宁省肿瘤医院 | 一种子宫内膜异位症诊断、预后标志物及其应用 |
| BR112022000945A2 (pt) * | 2019-07-22 | 2022-03-08 | Hoffmann La Roche | Métodos para avaliar se uma paciente tem endometriose ou está em risco de desenvolver endometriose, para selecionar uma paciente para terapia e para monitorar uma paciente que sofre de endometriose ou que está sendo tratada para endometriose |
| CN114144674A (zh) * | 2019-07-22 | 2022-03-04 | 豪夫迈·罗氏有限公司 | P物质作为用于子宫内膜异位症的非侵入性诊断的血液生物标志物 |
| US11965879B2 (en) | 2019-08-23 | 2024-04-23 | Mcmaster University | Method for diagnosing and assessing endometriosis |
| KR102242639B1 (ko) * | 2020-01-28 | 2021-04-21 | 고려대학교 산학협력단 | 간 섬유화 진단용 바이오마커 miRNA4668-5p |
| KR102316507B1 (ko) * | 2020-02-28 | 2021-10-22 | 차의과학대학교 산학협력단 | 난소 예비력 바이오마커 및 이의 용도 |
| CN111909997B (zh) * | 2020-09-09 | 2021-09-28 | 上海交通大学 | miRNA标志物在制备奥氮平治疗精神分裂症疗效评估方面的产品中的应用及试剂盒 |
| KR20240084586A (ko) * | 2022-12-06 | 2024-06-14 | 연세대학교 산학협력단 | 자궁내막증 진단용 조성물 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090317820A1 (en) | 2008-05-19 | 2009-12-24 | The Regents Of The University Of California | Micro-rna profile in human saliva and its use for detection of oral cancer |
| CN102301002A (zh) | 2008-11-12 | 2011-12-28 | 卡里斯生命科学卢森堡控股有限责任公司 | 使用外来体来确定表现型的方法和系统 |
| JP5808349B2 (ja) * | 2010-03-01 | 2015-11-10 | カリス ライフ サイエンシズ スウィッツァーランド ホールディングスゲーエムベーハー | セラノーシスのためのバイオマーカー |
| CA2825522A1 (fr) * | 2011-01-26 | 2012-08-02 | Cepheid | Procedes de detection du cancer du poumon |
| US20140024590A1 (en) * | 2011-02-18 | 2014-01-23 | Yale University | KRAS-Variant And Endometriosis |
| FR2984358A1 (fr) * | 2011-12-16 | 2013-06-21 | Genethon | Methodes pour le diagnostic de dystrophies musculaires |
| WO2013148151A1 (fr) | 2012-03-29 | 2013-10-03 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Acides microribonucléiques plasmatiques à titre de biomarqueurs de l'endométriose et du cancer de l'ovaire associé à l'endométriose (eaoc) |
| CA2931082C (fr) * | 2013-11-18 | 2024-01-23 | Diamir, Llc | Procedes d'utilisation de micro-arn provenant de liquides corporels permettant de detecter et de surveiller la maladie de parkinson |
| GB201403489D0 (en) * | 2014-02-27 | 2014-04-16 | Univ London Queen Mary | Biomarkers for endometriosis |
| US9650676B2 (en) | 2014-03-19 | 2017-05-16 | University Of South Carolina | Leukocyte MicroRNAS for use in diagnosis and treatment of endometriosis |
| WO2015148919A2 (fr) * | 2014-03-27 | 2015-10-01 | Yale University | Micro-arn circulants en tant que biomarqueurs pour l'endométriose |
| EP2924126B1 (fr) * | 2014-03-28 | 2018-04-18 | Tervisetehnoloogiate Arenduskeskus AS | Procédé d'utilisation de micro-ARN (miARN) pour la détection de l'endométriose |
| GB201603967D0 (en) * | 2016-03-08 | 2016-04-20 | Univ Birmingham | Biomarkers of traumatic brain injury |
| CA3035429A1 (fr) | 2016-08-30 | 2018-03-08 | Yale University | Micro-arn servant de biomarqueurs de l'endometriose |
| EP3676395A4 (fr) | 2017-08-30 | 2021-09-01 | Dot Laboratories, Inc. | Méthodes et compositions de détection et de traitement de l'endométriose |
| WO2020092672A2 (fr) | 2018-10-31 | 2020-05-07 | Yale University | Algorithme quantitatif pour endométriose |
| US11315660B2 (en) | 2018-10-31 | 2022-04-26 | Dot Laboratories, Inc. | Method of detecting and treating endometriosis in a female subject |
| CA3134382A1 (fr) | 2019-04-29 | 2020-11-05 | Hugh Taylor | Classificateurs pour la detection de l'endometriose |
-
2017
- 2017-08-30 CA CA3035429A patent/CA3035429A1/fr active Pending
- 2017-08-30 AU AU2017319325A patent/AU2017319325A1/en not_active Abandoned
- 2017-08-30 JP JP2019511953A patent/JP2019528081A/ja active Pending
- 2017-08-30 BR BR112019004075A patent/BR112019004075A2/pt unknown
- 2017-08-30 CN CN201780066779.9A patent/CN109890394A/zh active Pending
- 2017-08-30 SG SG11201901834WA patent/SG11201901834WA/en unknown
- 2017-08-30 WO PCT/US2017/049284 patent/WO2018044979A1/fr unknown
- 2017-08-30 EP EP17847431.8A patent/EP3506912B1/fr active Active
- 2017-08-30 MX MX2019002425A patent/MX2019002425A/es unknown
- 2017-08-30 SG SG10202102509TA patent/SG10202102509TA/en unknown
- 2017-08-30 US US16/329,436 patent/US10982282B2/en active Active
- 2017-08-30 KR KR1020197009115A patent/KR20190057305A/ko not_active Application Discontinuation
-
2021
- 2021-02-25 US US17/184,894 patent/US11220713B2/en active Active
- 2021-11-02 US US17/517,014 patent/US20220049312A1/en active Pending
-
2022
- 2022-09-16 JP JP2022147738A patent/JP2022188086A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022188086A (ja) | 2022-12-20 |
| US20210180134A1 (en) | 2021-06-17 |
| CA3035429A1 (fr) | 2018-03-08 |
| US20190276893A1 (en) | 2019-09-12 |
| US20220049312A1 (en) | 2022-02-17 |
| CN109890394A (zh) | 2019-06-14 |
| WO2018044979A1 (fr) | 2018-03-08 |
| EP3506912B1 (fr) | 2024-04-03 |
| KR20190057305A (ko) | 2019-05-28 |
| US11220713B2 (en) | 2022-01-11 |
| SG10202102509TA (en) | 2021-04-29 |
| EP3506912A4 (fr) | 2020-08-19 |
| MX2019002425A (es) | 2019-08-16 |
| BR112019004075A2 (pt) | 2019-05-28 |
| AU2017319325A1 (en) | 2019-03-21 |
| US10982282B2 (en) | 2021-04-20 |
| JP2019528081A (ja) | 2019-10-10 |
| EP3506912A1 (fr) | 2019-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201901834WA (en) | Micrornas as biomarkers for endometriosis | |
| SG11201804758QA (en) | Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab | |
| SG11201807252QA (en) | Anti-lag-3 antibodies | |
| SG11201907753TA (en) | Bispecific binding molecules that are capable of binding cd137 and tumor antigens, and uses thereof | |
| SG11201804086VA (en) | Methods and compositions for nucleic acid analysis | |
| SG11201808990QA (en) | Compositions for topical application of compounds | |
| SG11201810003UA (en) | Using programmable dna binding proteins to enhance targeted genome modification | |
| SG11201805950UA (en) | Self-assembled nanostructures and separation membranes comprising aquaporin water channels and methods of making and using them | |
| SG11201803703UA (en) | Anti-complement factor c1q fab fragments and uses thereof | |
| SG11201903771XA (en) | Binding molecules specific for asct2 and uses thereof | |
| SG11201807593TA (en) | Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers | |
| SG11201809374VA (en) | Cd40l-fc fusion polypeptides and methods of use thereof | |
| SG11201906844RA (en) | Biometric feature database establishing method and apparatus | |
| SG11201804712PA (en) | Biofuel | |
| SG11201901172QA (en) | A method for manufacturing a fuel component | |
| SG11201806432PA (en) | Methods for assessing risk of developing colorectal cancer | |
| SG11201807255YA (en) | Treatment of autoimmune diseases with combinations of rxr agonists and thyroid hormones | |
| SG11201810143PA (en) | Exon skipping oligomers for muscular dystrophy | |
| SG11201807038UA (en) | Rodents having a humanized tmprss gene | |
| SG11201811329UA (en) | Spheroids including biologically-relevant materials and related methods | |
| SG11201903012RA (en) | Anti-c1s antibodies and methods of use thereof | |
| SG11201809473QA (en) | Humanized anti-basigin antibodies and the use thereof | |
| SG11201903602RA (en) | Use of beta-catenin as a biomarker for treating cancers using anti-dkk-1 antibody | |
| SG11201805269QA (en) | Process for preparation of polyethylene nanocomposite | |
| SG11201906778RA (en) | Improved methods for assessing risk of developing breast cancer |